KIT and melanoma: In melanomas, the MAPK pathway is frequently hyperactivated by mutations in the BRAF gene (approximately 50% of melanomas) but also in NRAS (18%), KIT (9%), HRAS (2%) or KRAS (2%) genes (COSMIC database).